Assessing the impact of neoantigen load on checkpoint blockade efficacy

被引：0
|
作者：
Yalcin, Zeynep Kosaloglu [1 ]
Frentzen, Angela [1 ]
Premlal, Ashmitaa Logandha Ramamoorthy [1 ]
Sidney, John [1 ]
Greenbaum, Jason A. [1 ]
Sette, Alessandro [1 ,2 ]
Peters, Bjoern [1 ,2 ]
机构：
[1] La Jolla Inst Immunol, La Jolla, CA USA
[2] Univ Calif San Diego, Dept Med, San Diego, CA USA
来源：
JOURNAL OF IMMUNOLOGY | 2019年 / 202卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
70.16
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine
    Liu, Connor J.
    Schaettler, Maximilian
    Blaha, Dylan T.
    Bowman-Kirigin, Jay A.
    Kobayashi, Dale K.
    Livingstone, Alexandra J.
    Bender, Diane
    Miller, Christopher A.
    Kranz, David M.
    Johanns, Tanner M.
    Dunn, Gavin P.
    [J]. NEURO-ONCOLOGY, 2020, 22 (09) : 1276 - 1288
  • [22] Microbiome Impact on Melanoma Immune Checkpoint Blockade
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1199 - 1199
  • [23] Impact of antibiotic exposure on the efficacy of immune checkpoint blockade in MSI-H metastatic CRC
    Serpas, Victoria
    Rogers, Jane Elizabeth
    Xiao, Lianchun
    Mola-Rudd, Kerri
    Dasari, Arvind
    Kee, Bryan K.
    Overman, Michael J.
    Johnson, Benny
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [24] Microbial Metabolite Enhances the Efficacy of Immune Checkpoint Blockade
    不详
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (12) : 2318 - 2318
  • [25] Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
    Zahavi, David J.
    Weiner, Louis M.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (01)
  • [26] Combination Immune Treatment of a Highly Aggressive Orthotopic Murine Glioblastoma With Checkpoint Blockade Inhibition and Neoantigen Vaccination
    Liu, Connor
    Schaettler, Maximilian
    Bowman-Kirigin, Jay
    Bender, Diane
    Kobayashi, Dale K.
    Miller, Chris A.
    Johanns, Tanner M.
    Dunn, Gavin P.
    [J]. NEUROSURGERY, 2019, 66 : 44 - 45
  • [27] Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer
    Anagnostou, Valsamo
    Smith, Kellie N.
    Forde, Patrick M.
    Niknafs, Noushin
    Bhattacharya, Rohit
    White, James
    Adleff, Vilmos
    Phallen, Jillian
    Wali, Neha
    Hruban, Carolyn
    Guthrie, Violeta B.
    Rodgers, Kristen
    Naidoo, Jarushka
    Kang, Hyunseok
    Sharfman, William
    Georgiades, Christos
    Verde, Franco
    Illei, Peter
    Li, Qing Ka
    Gabrielson, Edward
    Brock, Malcolm
    Zahnow, Cynthia
    Baylin, Stephen B.
    Scharpf, Rob
    Brahmer, Julie R.
    Karchin, Rachel
    Pardoll, Drew M.
    Velculescu, Victor E.
    [J]. CANCER RESEARCH, 2017, 77
  • [28] Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Anagnostou, Valsamo
    Smith, Kellie N.
    Forde, Patrick M.
    Niknafs, Noushin
    Bhattacharya, Rohit
    White, James
    Zhang, Theresa
    Adleff, Vilmos
    Phallen, Jillian
    Wali, Neha
    Hruban, Carolyn
    Guthrie, Violeta B.
    Rodgers, Kristen
    Naidoo, Jarushka
    Kang, Hyunseok
    Sharfman, William
    Georgiades, Christos
    Verde, Franco
    Illei, Peter
    Li, Qing Kay
    Gabrielson, Edward
    Brock, Malcolm V.
    Zahnow, Cynthia A.
    Baylin, Stephen B.
    Scharpf, Robert B.
    Brahmer, Julie R.
    Karchin, Rachel
    Pardoll, Drew M.
    Velculescu, Victor E.
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 264 - 276
  • [29] Paravertebral Blockade for Mastectomy The Importance of Assessing Efficacy
    Ardon, Alberto E.
    Greengrass, Roy A.
    [J]. REGIONAL ANESTHESIA AND PAIN MEDICINE, 2014, 39 (06) : 562 - 563
  • [30] Predictive biomarkers of efficacy of checkpoint blockade inhibitors in cancer treatment
    Duruisseaux, Michael
    Lize-Dufranc, Cecile
    Badoual, Celine
    Bibeau, Frederic
    [J]. ANNALES DE PATHOLOGIE, 2017, 37 (01) : 46 - 54
12345